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ABSTRACT
Objectives: This study was conducted in order to produce translation, cultural adaptation, and validation of Assessment 
of Pelvic Floor Disorders and Their Risk Factors During Pregnancy and Postpartum Questionnaire (APFDQ) to Turkish in 
pregnant and postpartum population.
Material and methods: The study included 80 pregnant women. Internal consistency was tested using Cronbach’s alpha. 
Questionnaires were applied three different times in order to assess for sensitivity. Patients were asked to complete the 
questionnaire first in the third trimester, secondly in postpartum 6th week and finally in postpartum 6th month after birth. 
For translation process content, face/content validity, reliability, construct validity and reactivity studies were done. All 
women had undergone pelvic examination and prolapse was assessed by using Pelvic organ Prolapse Quantification System 
(POP-Q). Urinary symptoms were also evaluated with Urinary Distress Inventory (UDI-6) questionnaire.
Results: The mean age of patients was 27.7 ± 5.5 years. Forty-one (51.25%) of the patients had vaginal delivery and 
39 (48.75%) had a cesarean section. Above 96% of the patients had completed the questionnaires. POP-Q assessments and 
UDI-6 results were used to evaluate construct validity. Cronbach’s alpha results were found to be 0.7 for all the subscales of 
the questionnaire: bladder: 0.702, bowel: 0.744, prolapse: 0.701, sexual function: 0.706 respectively, indicating adequate 
reliability. The test/retest reliability was studied and Pabak values showed moderate reliability in the bowel, prolapse and 
sexuality, and good reliability for bladder subscale. The results of the patients were compared between pregnancy and 
postpartum to assess reactivity and shown to be reactive to changes. Also risk factors of the patients were assessed includ-
ing, family predisposition, maternal age over 35 years, BMI > 25, nicotine use, subjective inability to contract pelvic floor 
and sense of postpartum wound pain. 
Conclusions: The Turkish version of APFDQ is a reliable and valid tool. It can be used for assessing the risk factors, incidence, 
assessing degree of PFDs and evaluating the impact on quality of life in pregnant and postpartum women. 
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INTRODUCTION
Pelvic floor dysfunction (PFDs) is a complex of urinary 
incontinence (UI), fecal incontinence (FI), pelvic organ pro-
lapse (POP), sexual dysfunction, and other urogenital symp-
toms [1]. PFDs incidence was shown to be as high 67.5% of 
the women excluding pregnancy and postpartum period [2]. 
The prevalence of each pelvic floor was evaluated, and anal 
incontinence was found 19.8%; urinary incontinence, 50.7%; 
constipation, 33.2%; and obstructed defecation, 26.8% [3, 4]. 
Childbirth is shown to be  related to PFDs. Parity was 
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found to be correlated with urinary incontinence in 50% 
of the patients and with prolapse in 75% of the cases [5]. 
Postpartum assessment of pelvic floor in terms of PFDs 
could lead to early diagnosis and intervention, and we could 
provide a protective health care [6].
PFDs are linked to physical and emotional stress, causing 
psychological problems and decreased quality of life [7]. But 
most of the patients discuss these problems with healthcare 
providers. Although pregnancy and postpartum periods are 
accepted as high-risk factors for pelvic floor trauma, it has 
not been studied thoroughly [8]. Further studies are needed 
to understand the effect of pregnancy and delivery on the 
pelvic floor structure.
In our opinion, questionnaires are fundamental for 
detecting the adverse effect of the disease to quality of 
life. In Turkey there are no validated questionnaires to ad-
dress PFDs in pregnant and postpartum women. We aim 
to translate, validate and culturally adapt a APFDQ which 
detects PFDs regarding bladder function, bowel function, 
prolapse and sexual function with risk factors in pregnant 
and postpartum patients. Postpartum depression is also 
questioned to clarify the etiology of the decreased qual-
ity of life. 
This questionnaire was constituted on previously vali-
dated German pelvic floor questionnaires in urogynecology 
patients [9]. New sections were added regarding risk factors, 
childbirth and impact on quality of life. Some of the ques-
tions were removed in order to adapt the questionnaire to 
younger patients (Annex 1 and 2).
MATERIAL AND METHODS
The original version of APFDQ was adapted to Turkish 
in the study.
Validation permission for the questionnaire was taken 
from the developer, Dr. Kaven Baessler for the use. Ethical 
board approval was taken from Zeynep Kamil Research and 
Training Hospital (19.12.2018/164).
Translation and cultural adaptation
The following guidelines were followed in order to vali-
date the original version of APFDQ into Turkish [9].
Firstly, forward- backward translations were made for 
cross-cultural adaptations. The original German version 
APFDQ was translated to Turkish by a native speaker, 
then a professional translator performed a backward 
translation, followed by an expert committee including 
the researchers evaluated the version of the APFDQ. This 
version was applied, then volunteers in order to detect if 
there is any misunderstanding. Finally, the Turkish version 
of theAPFDQ was edited according to suggestions and 
used in patients. 
Questionnaire
The APFDQ was based on the validated Australian Pelvic 
Floor Questionnaire which has four domains including blad-
der, bowel, support and sexual function [10–13]. There are 
completely newly developed sections in the APFDQ for risk 
factors and the course of childbirth. Participants fulfilled the 
childbirth domain at postpartum 6th week, which elucidate 
the route of delivery, emotional effect of birth and postpar-
tum pain for patient.
Validity
Ten volunteers had completed the questionnaire and 
were interviewed by the researchers to find out if there were 
any misinterpretations. The version was also discussed in 
the study group and counseled to the experts on this topic.
Reliability
Internal consistency and test- retest analysis are used to 
establish reliability. For an adequate internal consistency, 
Cronbach’s Alpha value should be more 0.7 and more. 
The questionnaire was given to patients in weekly in-
tervals during the third trimester, to constitute test- retest 
reliability. The interval was shorter than the usual period for 
reliability regarding the concern for maintaining the same 
conditions in pregnant patients. PABAK value was used to 
establish the degree of agreement and intraclass correla-
tion coefficient (ICC) to demonstrate the agreement of the 
test- retest results of the individuals.
Reactivity “sensitivity to change”
The questionnaire was giving weekly two different times 
first during the third trimester, then again during postpar-
tum at 6th week and 6th month. 
Study population and data collection
The questionnaire was giving to 92 women attending 
routine visits in two tertiary clinics in Istanbul. Inclusion 
criterias were age between 18–40 years and having uncom-
plicated pregnancy. Exclusion criterias were inadequate 
Turkish language knowledge, having chronic diseases, 
neurological disorders, preeclampsia, gestational diabetes 
mellitus, or fetal abnormalities. 
Sample size was calculated taking into account the previ-
ous studies, with a power of 80% and α = 0.05 a score change 
of 1 in a domain (minimal important clinical difference) can be 
significantly detected from a sample size of n = 50 [12].
Analysis of data
The final version was validated according to COSMIN 
(The Consensus- based Standards for the selection of health 
Measurement Instruments) International guidelines [13].
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Statistical Analysis
Numeric variables were expressed as the mean and 
standard deviation or as the median (minimum–maximum), 
depending on the distribution of the data. The normality 
was determined using the Shapiro-Wilk test. Internal con-
sistency of the scale was assessed with Cronbach’s alpha co-
efficient. Intra class correlation coefficient and Kappa along 
with PABAK (Prevalence adjusted Bias adjusted Kappa) were 
used for test-retest reliability. Hence some of the tables 
included sparse data, i.e. concordant cell frequencies were 
high and discordant frequencies were low, PABAK along 
with Kappa was reported. Effect sizes of the 6th week to 
after delivery and the 3rd trimester to after delivery was 
calculated by dividing the difference between the mean of 
measurements before and after delivery by the standard 
deviation of measurement before delivery (Δ/SD) for as-
sessing the responsiveness of the scale. Comparisons of 
before and after delivery scores were also performed with 
Wilcoxon signed rank test.
Concurrent and construct validity was assessed with 
spearman correlation coefficient.
Interpretations of Kappa and PABAK values were per-
formed according to the classification for the strength of 
agreement, which considers κ values of 1–0.81 to be almost 
in perfect agreement, 0.80–0.61 to be in substantial agree-
ment, 0.60–0.41 to be in moderate agreement, 0.40–0.21 to 
be in fair agreement, and < 0.20 to be in slight agreement. 
p < 0.05 was considered statistically significant. 
RESULTS
A total of 92 women in the of third trimester pregnancy 
were included the study. Twelve were excluded due to failure 
to follow-up. The remaining 80 patients were interviewed 
during the third trimester, postpartum 6th week and postpar-
tum 6th month. Forty-one (51.25%) patients had vaginal de-
livery and 39 (48.75%) patients had a cesarean section. Figure 
1 shows the study course. Thirty-five (43.75 %) women were 
primiparous and 56.25% were multiparous. The mean age 
of the women was 27.7 ± 5.5 years. The mean parity was 
1.1 ± 1.1. The mean body mass index was 26.32 ± 3.14 of 
the patient group. Socio-demographic characteristics of the 
patients were summarized in Table 1. Mean gravida of the 
patients was 2.3 ± 1.4. Mean of the maximum weight of the 
babies delivered was 2332.3 ± 1626.1 grams. None of the 
patients had operative delivery. Obstetrics characteristics 
of the patients were summarized in Table 2. Prevalence for 
PFDs of the study population was shown in Table 3.
Internal consistency reliability
Cronbach’s alpha value of domains were calculated and 
found to be over 0.7 points which is enough to show reli-
ability of the questionnaire. 
Test-retest reliability
PABAKvalues and ICC values were used to assess test-re-
test reliability and shown in Table 4. Therefore, while bladder 
Table 1. Sociodemographic characteristics of the population
Mean ± SD
Age 27.7 ± 5.5
BMI 28.6 ± 4.8
Income status  
   Low-income 26 (32.9%)
   Middle-income 40 (50.6%)
   High-income 13 (16.5%)
Chronic disease  
   Yes 69 (87.3%)
   No 10 (12.7%)
Previous abdominal surgery  
   Yes 55 (69.6%)
   No 24 (30.4%)
Mean ± standard deviation was given for quantitative variables, whereas n (%) were 
given for qualitative ones
Table 2. Obstetric characteristics of the study population
Gravida (mean ± SD ) 2.3 ± 1.4
Parity (mean ± SD ) 1.1 ± 1.1
Number of vaginal delivery (n, %) 41 (51.25%)
Number of cesarean delivery (n, %) 39 (48.75)
Episiotomy (n,%) 11 (22.91%)
Mean birth wieght (mean ± SD) 2332.3 ± 1626.1
Mean ± standard deviation was given for quantitative variables, whereas n (%) were 
given for qualitative ones
Table 3. Prevalence of the PFDs in study population
Third trimester Postpartum 6th week Postpartum 6th month
Urinary incontinence n (%) 78 (98.73%) 72 (90%) 64 (80%)
Anal incontinence n (%) 23 (28.75%) 18 (22.5%) 14 (17.5%)
Genital prolapse n (%) 26 (32.5%) 34 (42.5%) 31 (38.75%)
Sexual symptoms n (%) 45 (56.25%) 62 (77.5%) 32 (40%)
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and bowel showed acceptable internal consistency along 
with good test-retest reliability; prolapse and sexuality had 
acceptable internal consistency along with good and mod-
erate test-retest reliability, respectively.
Content validity
The rate of missing answers did not exceed 4% for any 
of the questions in the final questionnaire. 
Construct validity
Patients’ bladder scores of the questionnaire was found 
to be significantly correlated to UDI-6 (rho: 0.806, p: 0.000), 
also prolapse scores were correlated to POP-Q scores sig-
nificantly (rho: 0.574, p: 0.000).
Reactivity and scoring system
Mean scores of the domains were statistically different 
between pregnant and postpartum patients indicating the 
questionnaire is reactive to the changes (p < 0.01) (Tab. 5).
DISCUSSION
Here in this study we found showing that the Turkish 
version of the APFDQ is a reliable tool for evaluating pelvic 
floor disorders in pregnancy and postpartum period. Also it 
is a reliable questionnaire that we could follow the changes 
in different situations. The study population had a higher 
ratio of patients with chronic diseases (87.3%). This might 
be explained by conducting the study in a tertiary center.
Pelvic floor dysfunction after birth is usually accepted 
as a “normal” situation that patients do not discuss with 
their healthcare professionals. So, it is underestimated and 
not well evaluated unless adressing the symptoms [14]. 
Questionnaires are accepted as a part of standard evalu-
ation methods for pelvic floor disorders [15]. Pregnancy 
and delivery are well known factors for PFDs [16]. Yet there 
are not comprehensive questionnaires in the literature for 
pregnant and postpartum patients. 
In the literature there are questionnaires which evalu-
ates PFDs such as Pelvic Floor Disorders Inventory-20 (PFDI-
20), Pelvic Floor Distress Inventory (PFIQ-7), Pelvic Floor 
Disorders Inventory-46 (PFDI-46), Pelvic Floor Distress 
Inventory (PFIQ-31), International Consultation on In-
continence- Vaginal Symptoms (ICIQ-VS), Australian Pel-
vic Floor Questionnaire (or Australian PFQ), Pelvic Floor 
Bother Questionnaire (PFBQ), electronic Personal Assess-
ment Questionnaire ePAQ-PF, and Pelvic Floor Dysfunction 
(PFD) [17–19]. 
PFDI-46 and PFIQ-31 are very time consuming, so 
new shorter versions were established as PFDI-20 and 
PFIQ-7. However, the new versions do not cover all the 
aspects of the PFDs and quality of life [20–21]. ICIQ-VS does 
not contain bladder and bowel functions [22]. From the 
above mentioned questionnaires, ePAQ, FPFQ and PFBQ 
are the only ones that evaluate all these areas but there are 
not widely used in the literature [23, 24]. ePAQ is not com-
monly used because of a license obligation. PFBQ is only 
translated to four languages so far and questions were not 
well distributed. FPFQ seems to address all the areas as it is 
newly developed, and it has not been widely translated to 
other languages [25–26].
None of the questionnaires above except APFDQ were 
originally developed to postpartum patients. APFDQ is also 
designed to evaluate specific risk factors for PFDs in post-
partum period. 
Table 4. Test-retest reliability
 Cronbach’s alpha ICC Pabak
Bladder 0.702 0.863 1.00
Bowel 0.744 0.714 0.90
Prolapse 0.701 0.735 0.54
Sexuality 0.706 0.626 0.67
Table 5. Reactivity
 3rd trimester 6th week 6th month ES1 p ES2 p
Bladder 1.88 (0–5) 1.88 (0–4.58) 0.42 (0–3.75) 1.46 < 0.001 1.57 < 0.001
Bowel 1.29 (0–5.16) 0.97 (0–4.52) 0.97 (0–2.26) 0.5 < 0.001 0.41 0.003
Prolapse 0 (0–2.5) 0.6 (0–2.5) 1.25 (0–2.92) –1.25 < 0.001 –2.03 < 0.001
Sexuality 1.67 (0–4.17) 0.9 (0–3.75) 0.5 (0–2.92) 0.77 0.005 0.4 0.003
Medians (range) were given; ES — Cohen’s effect size was calculated by dividing the difference between the mean of measurements before and after delivery by the standard 
deviation of measurement before delivery (Δ/SD); ES1 — effect size of the third trimester to the 6th week after delivery; ES2 — effect size of after the 6th week to after the 6th 
month delivery; comparison between the third trimester and postpartum, p values are based on Wilcoxon signed-rank test
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It is important to detect these symptoms in the early 
period to prevent future advanced PFDs, and make an ap-
propriate intervention. In this study we aimed to translate 
this questionnaire in order to detect PFDs in our popula-
tion and reduce the adverse effect of PFDs to quality of life. 
Administering pelvic muscle training in the postpartum 
period (PFMT) is proven to improve pelvic floor function 
and quality of life (QOL) of the patients [27]. Although there 
are conflicting data in the literature, a recent randomised 
study showed that a two-tiered, self-selection approach had 
increased the pelvic floor function and QOL in women with 
or without incontinence. The two- tiered approach consists 
of an informative session about anatomy and physiology 
and then practical data about exercise was taught and 
a PFMT was constituted for home [27]. Cochrane review 
published in 2014 also suggests that PFMT could prevent 
incontinence for 6 months in continent women during preg-
nancy [28]. Also, women with urinary incontinence were 
found to benefit from PFMT up to 1 year after delivery [28]. 
Cochrane review published in 2017 suggested that if offered 
to continent women in early pregnancy, PFMT programme 
could reduce urinary incontinence in late pregnancy and 
postpartum period [29].
CONSLUSIONS
Linguistic validation is an important step in the vali-
dation process. In order to have a better understanding, 
translations were done by native speakers then it was con-
trolled by the expert committee. At first, 10 volunteers were 
involved to the study and interviewed face to face in order 
to modify misunderstandings. 
According to the results of this study, the Turkish version 
of APFDQ was a valid and reliable tool to assess pelvic floor 
disorders in the period of pregnancy and postpartum. The 
Turkish version of APFDQ could be used to evaluate the im-
mediate status of the patients during pregnancy and post-
partum or could be used to follow the changes according to 
the score changes. Discriminant validity showed a significant 
difference between the pregnancy and postpartum periods 
in all the subscales of the questionnaire. The Turkish version 
of APFDQ has high internal consistency, is reproducible and 
high construct validity, and can detect the degree of pelvic 
floor dysfunction. It has a high correlation with UDI 6 and 
moderate correlation with POP-Q. 
The Turkish version of the self-administered APFDQ 
seems to be a reliable and valid instrument for evaluat-
ing PFDs symptoms severity and quality of life in Turkish 
speaking women.
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MODULE RISK FACTORS RISK
Height    cm Weight    kg Weight before pregnancy For BMI    kg BMI   .     > 25
Age   years   > 35
Are there any women in your family to whom you are related by blood who have urinary 
incontinence, fecal incontinence, or prolapse of the pelvic organs?   no   don’t know   yes
Do you smoke?   no   stopped   yes
Can you voluntarily contract your pelvic floor?   yes   don’t know   no
Bladder function 0 1 2 3
1. How often do you urinate during the day? 
Pollakiuria Every 3 hours Every 2 hours Once every hour More often
2. How often do you wake up at night 
because you need to urinate? 
Nocturia
2× 3× More than 3×
3. Do you lose urine in your sleep? 
Nocturnal enuresis Never
Sometimes 
— less than once a week
Often 
— once a week or more
Usually 
— every day
4. Is the urge to urinate so strong that you 
must immediately rush to the toilet? 
Strong urge to urinate
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
5. When you have a sudden strong urge to 
urinate, do you leak urine before you reach 
the toilet? 
Urge incontinence
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
6. Do you leak urine when coughing, 
sneezing, laughing, lifting or during 
sports? 
Stress incontinence
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
7. Is your urinary stream weak, slow or 
prolonged? 
Urinary stream
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
8. Do you feel that you can accurately assess 
how full your bladder is? 
Bladder estimate
Yes — always Usually Sometimes No — never
9. Do you feel that you cannot completely 
empty your bladder? 
Residual urine
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
10. Do you need to squeeze to urinate? 
Squeeze Never
Sometimes 
— less than once a week
Often 
— once a week or more
Usually 
— every day
11. Do you wear panty liners or sanitary pads 
because of urine leakage?
 Pads
Never Sometimes — only as prophylaxis
Often 
— during sports/during colds
Usually 
— every day
12. Do you limit the amount you drink to avoid 
leaking urine?
 Drinking patterns
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
13. Do you experience a burning or dragging 
sensation or pain when you urinate?
 Dysuria
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
14. How often do you have urinary tract 
infections?
 UTI
Rarely or never 1–3x per year 4–12× per year 1× or more/month
Annex 1. The new version of the questionnaire*; Pelvic Floor Questionnaire for pregnant and post partum women
*This is a simple translation of the questionnaire. This version has not been validated in English
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15. Does the involuntary 
loss of urine adversely 
affect your daily life? 




I do not have 
symptoms
Not at all A little Quite a lot Very much
16. How much do your 
bladder symptoms 
bother you?
 Psychological stress from 
bladder symptoms
Not applicable, 
I do not have 
symptoms
Not at all A little Quite a lot Very much
Bowel function 0 1 1 2
1. How often do you have a bowel 
movement?
 Frequency
Every 3 days to 
once a day More than 1x per day Every 3 days or less often
less than once 
a week
2. What is the normal consistency of your 
stools?
 Consistency
soft or shaped varying consistency very hard thin/mushy
Bowel function 0 1 2 3
3. Do you need to strain to have a bowel 
movement?
 Straining
Never Sometimes — less than once a week




4. Do you suffer from constipation?
 Constipation Never
Sometimes — less than once 
a week




5. Do you experience involuntary flatulence 
which you cannot suppress?
 Flatus incontinence
Never Sometimes — less than once a week




6. Do you experience an urge to defecate 
which you cannot suppress?
 Urge bowel incontinence
Never Sometimes — less than once a week




7. Do you find traces of fecal soiling on your 
underwear or pads?
 Stool smears
Never Sometimes — less than once a week




8. Do you experience accidental bowel 
leakage with loss of feces?
 Fecal incontinence
Never Sometimes — less than once a week




9. Do you have the feeling that you cannot 
completely empty your bowels?
 Bowel dysfunction
Never Sometimes — less than once a week




10. Do the symptoms 
adversely affect your 
daily life? (planning your 




I do not have 
symptoms
Not at all A little Quite a lot Very much
11. How much do your 
bowel symptoms bother 
you?
 Psychological stress from 
bowel symptoms
Not applicable, 
I do not have 
symptoms
Not at all A little Quite a lot Very much
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Prolapse 0 1 2 3
1. Do you feel as though there is a foreign 
body in your vagina?
 Foreign body
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
2. Do you feel that your vagina or uterus may 
have dropped?
 Prolapse feeling
Never Sometimes — less than once a week
Often 
— once a week or more
Usually 
— every day
3. Do you have the feeling that your vagina or 
uterus drops when you lift something, walk 
or run?
 Prolapse under stress
Not at all A little Quite a lot Very much
4. Do these symptoms 
adversely affect your 
daily life? (e.g. sports 




I do not have 
symptoms
Not at all A little Quite a lot Very much
5. How much does prolapse 
bother you?
 Psychological stress from 
prolapse
Not applicable, 
I do not have 
symptoms
Not at all A little Quite a lot Very much
Sexuality
Are you sexually active?
Sexually active   Not at all   Rarely   Regularly
If you do not have sexual intercourse, why not?
Abstinent because   no partner
  partner 
         has problems/ 
         /is impotent
  don’t get 
         aroused/ 
         /not interested
  Sex is
unpleasant for me because
. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Have you had sexual experiences which 
distress you very much?
Sexual trauma
  No   Yes
0 1




0 1 2 3
2. How does your vagina feel during 
intercourse?
 Vaginal sensation
feel a lot don’t feel much don’t feel anything painful
3. Do you think that your vagina is too slack or 
too wide?
 Vaginal width
No — never Sometimes Often Always
4. Do you think that your vagina is too tight or 
too firm?
 Vaginismus
No — never Sometimes Often Always
5. Do you experience pain during intercourse?
 Dyspareunia No — never Sometimes Often Always
1 1 2
6. If you experience pain during intercourse, 
where is the pain sited? at the beginning of the vagina deep inside/in the pelvis Both
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0 1 2 3
7. Do you have involuntary loss of urine or 
feces during sex?
 Coital incontinence
No — never Sometimes Often Always
8. Do these symptoms 




I do not have 
symptoms
Not at all A little Quite a lot Very much
9. How much do these 
symptoms bother you?
 Psychological stress 
because of sex
Not applicable, 
I do not have 
symptoms
Not at all A little Quite a lot Very much









Score   / 48  =   . 
Score   / 31  =   . 
Score   / 15  =   . 
Score   / 24  =   . 
× 10 =  
× 10 =  
× 10 =  
× 10 =  
Bladder score + bowel score + prolapse score + sex score =                                           .                 
Postpartum module Risk
How many children have you born? How many births were ventouse (vacuum, suction cup)-assisted births?
How many were born by cesarean section? How many births were forceps-assisted births?
How heavy was your heaviest child at birth?    g   > 4000g
Was the sphincter muscle, bowel or perineum injured 
during any of your births (3rd or 4th degree perineal tear)?   No   Yes
Did you have pain postpartum in the area of the vagina, 
perineum or bowel/anus/rectum?   No   Yes
Do you feel that you have since been able to process the 
birth pains or the pain experienced after the birth?   Yes   Largely   A little   No
Do you feel that you have since been able to process the 
fears you had during the birth?   Yes   Largely   A little   No
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AUSTRALIAN PELVIC FLOOR 
QUESTIONNAIRE
Patient’s Name: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Date of Birth: . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Date completed: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Please circle your most applicable answer. Consider your experience during the last month.
BLADDER FUNCTION  ( . . . . . .  / 45)
Q1. How many times do you pass urine in 
a day?
0 Up to 7
1 Between 8–10
2 Between 11–15
3 More than 15





3 More than 3 times
Q3. Do you wet the bed before you wake up 
at night?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Always — every night
Q4. Do you need to rush/hurry to pass urine 
when you get the urge?
0 Can hold on
1 Occasionally must rush — less than once/week
2 Frequently must rush — once or more/week
3 Daily
Q5. Does urine leak when you rush or hurry 
to the toilet or can’t you make it in time?
0 Not at all
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q6. Do you leak with coughing, sneezing, 
laughing or exercising?
0 Not at all
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q7. Is your urinary stream (urine flow) weak, 
prolonged or slow?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q8. Do you have a feeling of incomplete 
bladder emptying?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q9. Do you need to strain to empty your 
bladder?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q10. Do you have to wear pads because of 
urinary leakage?
0 None — Never
1 As a precaution
2 When exercising/during a cold
3 Daily
Q11. Do you limit your fluid intake to 
decrease urinary leakage?
0 Never
1 Before going out
2 Moderately
3 Always
Q12. Do you have frequent bladder 
infections?
0 No
1 1–3 per year
2 4–12 per year
3 More than one per month
Q13. Do you have pain in your bladder or 
urethra when you empty your bladder?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q14. Does urine leakage affect your routine 
activities like recreation, socializing, 
sleeping, shopping etc?




Q15. How much does your bladder problem 
bother you?




Other symptoms (haematuria, pain etc.)
BOWEL FUNCTION  ( . . . . . .  / 34)
Q16. How often do you usually open your 
bowels?
0 Every other day or daily
1 Less than every 3 days
2 Less than once a week
0 More than once per day







Q18. Do you have to strain to empty your 
bowels?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q19. Do you use laxatives to empty your 
bowels?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q20. Do you feel constipated?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q21. When you get wind or flatus, can you 
control it, or does wind leak?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Annex 2. The old version of the questionnaire
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AUSTRALIAN PELVIC FLOOR 
QUESTIONNAIRE
Patient’s Name: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Date of Birth: . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Date completed: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Q22. Do you get an overwhelming sense of 
urgency to empty bowels?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q23. Do you leak watery stool when you do 
not mean to?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q24. Do you leak normal stool when you do 
not mean to?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q25. Do you have a feeling of incomplete 
bowel emptying?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q26. Do you use finger pressure to help 
empty your bowel?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q27. How much does your bowel problem 
bother you?




PROLAPSE SYMPTOMS  ( . . . . . .  / 15)
Q28. Do you have a sensation of tissue 
protrusion/lump/bulging in your vagina?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q29. Do you experience vaginal pressure or 
heaviness or a dragging sensation?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q30. Do you have to push back prolapse in 
order to void?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q31. Do you have to push back your 
prolapse to empty your bowels?
0 Never
1 Occasionally — less than once per week
2 Frequently — once or more per week
3 Daily
Q32. How much does your prolapse bother 
you?




Other Symptoms: (problems: walking/sitting,
pain, vaginal bleeding)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SEXUAL FUNCTION  ( . . . . . .  / 21)
Q33. Are you sexually active?
  No
  Less than once per week
  Once or more per week
  Daily or most days
If you are not sexually active, please continue 
to answer questions 34 & 42.
Q34. If you are not sexually active, please 
tell us why?
  Do not have a partner
  I am not interested
  My partner is unable
  Vaginal dryness
  Too painful
  Embarrassment due to the prolapse/ 
         /incontinence
  Other reasons: . . . . . . . . . . . . . . . . . . . . . . . . . . . .



























Q40. Where does the pain during 
intercourse occur?
0 Not applicable, I do not have pain
1 At the entrance to the vagina
2 Deep inside, in the pelvis
3 Both at the entrance & in the pelvis






Q42. How much do these sexual issues 
bother you?
  Not applicable




Q43. Other symptoms? (faecal incontinence, vaginismus etc)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
